Novartis AG (NVS) Admits 2 Ex-Employees Plus Prominent Japanese Doc Involved in Data Scandal
7/23/2013 7:43:08 AM
Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
Two former Novartis AG (NYSE:NVS) employees were involved in a massive data fabrication scandal surrounding the Kyoto Heart Study, a post-market trial examining the company's Valsartan drug in more than 3,0000 patients. The scandal broke when prominent Japanese cardiologist Dr. Hiroaki Matsubara was accused of fabricating study results, prompting medical journals Circulation, Circulation Research, and Hypertension to retract 5 studies connected to the doctor's Kyoto Heart Study research, according to TheHeart.org. Novartis has since announced that it wrapped up a 3rd-party investigation of its employees' involvement, confirming their role in the analysis of the heart study results.
Help employers find you! Check out all the jobs and post your resume.
comments powered by